4.7 Article

Modulating effects of RAMPs on signaling profiles of the glucagon receptor family

Journal

ACTA PHARMACEUTICA SINICA B
Volume 12, Issue 2, Pages 637-650

Publisher

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.07.028

Keywords

G protein-coupled receptor; Glucagon receptor family; Receptor activity-modulating protein; Signaling; Allosteric modulation; GPCR-RAMP interaction; Receptor pharmacology; Ligand selectivity

Funding

  1. National Key R&D Programs of China [2018YFA0507000]
  2. National Science Foundation of China [81773792, 81973373, 81872915, 82073904]
  3. National Science and Technology Major Project of China-Key New Drug Creation and Manufacturing Program [2018ZX09735-001, 2018ZX09711002-002-005]
  4. Novo Nordisk-CAS Research Fund [NNCAS-2017-1CC]

Ask authors/readers for more resources

This study comprehensively investigated the interactions between receptor activity-modulating proteins (RAMPs) and G protein-coupled receptors (GPCRs) using a bioluminescence resonance energy transfer (BRET) approach. The results revealed that RAMPs modulate the signal transduction of glucagon receptor family members in a receptor-specific manner. These findings provide new insights into the role of RAMPs in ligand recognition and receptor activation.
Receptor activity-modulating proteins (RAMPs) are accessory molecules that form complexes with specific G protein-coupled receptors (GPCRs) and modulate their functions. It is established that RAMP interacts with the glucagon receptor family of GPCRs but the underlying mechanism is poorly understood. In this study, we used a bioluminescence resonance energy transfer (BRET) approach to comprehensively investigate such interactions. In conjunction with cAMP accumulation, Gaq activation and b-arrestin1/2 recruitment assays, we not only verified the GPCR-RAMP pairs previously reported, but also identified new patterns of GPCR-RAMP interaction. While RAMP1 was able to modify the three signaling events elicited by both glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), and RAMP2 mainly affected b-arrestin1/2 recruitment by GCGR, GLP-1R and glucagon-like peptide-2 receptor, RAMP3 showed a widespread negative impact on all the family members except for growth hormone-releasing hormone receptor covering the three pathways. Our results suggest that RAMP modulates both G protein dependent and independent signal transduction among the glucagon receptor family members in a receptor-specific manner. Mapping such interactions provides new insights into the role of RAMP in ligand recognition and receptor activation. (c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available